Elena Vendramini

Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group

Libi Hertzberg, Elena Vendramini, Ithamar Ganmore et al. · Blood · 2009 · 344 citations · Full text

Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia

Chiara Palmi, Elena Vendramini, Daniela Silvestri et al. · Leukemia · 2012 · 112 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +9

Early Relapse in ALL Is Identified by Time to Leukemia in NOD/SCID Mice and Is Characterized by a Gene Signature Involving Survival Pathways

Lüder Hinrich Meyer, Sarah M. Eckhoff, Manon Queudeville et al. · Cancer Cell · 2011 · 90 citations · Full text

Hematological Malignancy, Nod/scid Mice, All Is +11

MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndrome

Lital Shaham, Elena Vendramini, Yubin Ge et al. · Blood · 2014 · 85 citations · Full text

NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components

Federico Pozzo, Tamara Bittolo, Elena Vendramini et al. · Leukemia · 2017 · 61 citations · Full text

Hematological Malignancy, Chromatin, Nucleophosmin 1 +8